I focus on small-molecule discovery across anti-infectives and nuclear receptor pharmacology: design, synthesis, SAR, permeability and efflux profiling, and mechanism. Programs include antibiotic adjuvants and probes for Gram-negative bacteria, modulators for cardiometabolic and renal indications, and inhibitors of complement proteases.